MAC Implementation File 8 - New Technology Add-on Payment (NTAP) - Technologies NO LONGER Receiving NTAP in FY 2027			
Technology	Maximum Add-on Payment in FY 2026	ICD-10-CM/PCS Coding Used to Identify Cases Eligible for NTAP	Alternative Pathways Status
Aveir AR Leadless Pacemaker	"$10,725.00"	X2H63V9	Breakthrough Device
Aveir Leadless Pacemaker (Dual-Chamber)	"$15,600.00"	X2H63V9 in combination with X2HK3V9	Breakthrough Device
Ceribell Status Epilepticus Monitor	$913.90	XX20X89	Breakthrough Device
CYTALUX (pafolacianine) (lung indication)	"$2,762.50"	"8E0W0EN, 8E0W3EN, 8E0W4EN, 8E0W7EN, or 8E0W8EN"	
DefenCath (taurolidine/heparin)	"$3,656.10"	XY0YX28	QIDP
DETOUR System	"$16,250.00"	"X2KH3D9, X2KH3E9, X2KJ3D9, or X2KJ3E9 "	Breakthrough Device
EPKINLY (epcoritamab-bysp) and COLUMVI (glofitamab-gxbm)*	"$6,504.07"	"XW013S9, XW033P9, or XW043P9"	
Phagenyx System	"$3,250.00"	XWHD7Q7	Breakthrough Device
REZZAYO (rezafungin for injection) 	"$4,387.50"	XW033R9 or XW043R9	QIDP
SAINT Neuromodulation System	"$12,675.00"	X0Z0X18	Breakthrough Device
TOPS System	"$11,375.00"	XRHB018 in combination with M48.062 	Breakthrough Device
XACDURO (sulbactam/durlobactam)	"$13,680.00"	XW033K9 or XW043K9in combination withone of the following: Y95 and J15.61;ORJ95.851 and B96.83	QIDP
RECELL Autologous Cell Harvesting Device	"$4,875.00"	"0HR0X72, 0HR1X72, 0HR2X72, 0HR3X72, 0HR4X72, 0HR5X72, 0HR6X72, 0HR7X72, 0HR8X72, 0HR9X72, 0HRAX72, 0HRBX72, 0HRCX72, 0HRDX72, 0HREX72, 0HRFX72, 0HRGX72, 0HRHX72, 0HRJX72, 0HRKX72, 0HRLX72, 0HRMX72, or 0HRNX72 in combination with: any of the codes listed in the additional sheet for the RECELL Autologous Cell Harvesting Device"	Breakthrough Device
			
*These technologies were determined to be substantially similar to each other and were therefore considered as one for new technology add-on payments under the IPPS.			
